INDIA – ANTI-BIOTIC

BY SWINEETHA DIAS WICKRAMANAYAKA
INDIA'S Alkem Laboratories is introducing a new antibiotic branded Megapime into its home market. It has been approved as a stand-alone drug which can be administered, without waiting for an exact diagnosis, to serious patients suffering from fever who have a low white cell count. It is a fourth generation cephalosporin active against a broader spectrum of bacteria than third generation drugs.



Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.